[1]
Zhai KF, Duan H, Luo L, et al. Protective effects of paeonol on inflammatory response in IL-1beta-induced human fibroblast-like synoviocytes and rheumatoid arthritis progression via modulating NF-kappaB pathway. Inflammopharmacol 2017; 25: 523-32.
[2]
Zhai KF, Duan H, Chen Y, et al. Apoptosis effects of imperatorin on synoviocytes in rheumatoid arthritis through mitochondrial/caspase-mediated pathways. Food Funct 2018; 9: 2070-9.
[3]
Zhang Y, Bai M, Zhang B, et al. Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation. Sci Rep 2015; 8: 15924.
[4]
Nanke Y, Yago T, Kotake S. The effects of disease modifying anti-rheumatic drugs on osteoclastogenesis and bone destruction in rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi 2011; 34: 493-500.
[5]
Bohler C, Radner H, Ernst M, et al. Rheumatoid arthritis and falls: the influence of disease activity. Rheumatology 2012; 51: 2051-7.
[6]
Liu SH, Chuang WC, Lam W, Jiang Z, Cheng YC. Safety surveillance of traditional Chinese medicine: Current and future. Drug Saf 2015; 38: 117-28.
[7]
Lu S, Wang Q, Li G, Sun S, Guo Y, Kuang H. The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms. J Ethnopharmacol 2015; 176: 177-206.
[8]
Duan H, Zhai KF, Cao WG, Gao GZ, Shan LL, Zhao L. The Optimum Extraction Process for Radix glycyrrhizae and Angelica dahurica (Fisch.) Benth.et Hook with Orthogonal Design. Indian J Pharm Edu Res 2017; 51: S631-6.
[9]
Zhai K, Gao G, Cao W, Zhao L, Fang X, Duan H. Simultaneous HPLC determination of four active compounds in fengshiding capsules, a chinese medicine. Indian J Pharm Sci 2014; 76: 445-9.
[10]
Shen P, Shen J, Sun C, et al. A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy. BMC Complement Altern Med 2016; 16: 312.
[11]
Wei Y, Ito Y. Preparative isolation of imperatorin, oxypeucedanin and isoimperatorin from traditional Chinese herb “bai zhi”Angelica dahurica (Fisch. ex Hoffm) Benth. et Hook using multidimensional high-speed counter-current chromatography. J Chromatogr A 2006; 1115: 112-7.
[12]
Zhai KF, Duan H, Khan GJ, et al. Salicin from Alangium chinense Ameliorates Rheumatoid Arthritis by Modulating the Nrf2-HO-1-ROS Pathways. J Agric Food Chem 2018; 66: 6073-82.
[13]
Wei P, Zhang T, Dong H, et al. Anti-inflammatory and antiviral activities of cynanversicoside A and cynanversicoside C isolated from Cynanchun paniculatum in influenza A virus-infected mice pulmonary microvascular endothelial cells. Phytomedicine 2017; 36: 18-25.
[14]
Xie W, Hao Z, Zhou X, et al. Arbuscular mycorrhiza facilitates the accumulation of glycyrrhizin and liquiritin in Glycyrrhiza uralensis under drought stress. Mycorrhiza 2018; 28: 285-300.
[15]
Zhai KF, Duan H, Cui CY, et al. Liquiritin from Glycyrrhiza uralensis Attenuating Rheumatoid Arthritis via Reducing Inflammation, Suppressing Angiogenesis, and Inhibiting MAPK Signaling Pathway. J Agric Food Chem 2019; 67: 2856-64.
[16]
Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. Mol Biosyst 2014; 10: 1014-22.
[17]
Liu ZH, Sun XB. [Network pharmacology: new opportunity for the modernization of traditional Chinese medicine]. Yao Xue Xue Bao 2012; 47: 696-703.
[18]
Mao Y, Hao J, Jin ZQ, et al. Network pharmacology-based and clinically relevant prediction of the active ingredients and potential targets of Chinese herbs in metastatic breast cancer patients. Oncotarget 2017; 8: 27007-21.
[19]
Lv YN, Li SX, Zhai KF, Kou JP, Yu BY. Network pharmacology-based prediction and verification of the molecular targets and pathways for schisandrin against cerebrovascular disease. Chin J Nat Med 2014; 12: 251-8.
[20]
Li S, Zhang B, Jiang D, Wei Y, Zhang N. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 2010; 11: S6.
[21]
Li F, Lv YN, Tan YS, et al. An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases. Acta Pharmacol Sin 2015; 36: 1337-48.
[22]
Hopkins AL. Network pharmacology. Nat Biotechnol 2007; 25: 1110-1.
[23]
Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008; 4: 682-90.
[24]
Wang N, Zhao G, Zhang Y, et al. A network pharmacology approach to determine the active components and potential targets of curculigo orchioides in the treatment of osteoporosis. Med Sci Monit 2017; 23: 5113-22.
[25]
Roelofs MF, Wenink MH, Brentano F, et al. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Ann Rheum Dis 2009; 68: 1486-93.
61
5